000 | 01932 a2200529 4500 | ||
---|---|---|---|
005 | 20250515162627.0 | ||
264 | 0 | _c20090723 | |
008 | 200907s 0 0 eng d | ||
022 | _a1550-7416 | ||
024 | 7 |
_a10.1208/s12248-009-9090-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLester, Henry A | |
245 | 0 | 0 |
_aNicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. _h[electronic resource] |
260 |
_bThe AAPS journal _cMar 2009 |
||
300 |
_a167-77 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAcetylcholine _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDrug Discovery |
650 | 0 | 4 |
_aEndoplasmic Reticulum _xdrug effects |
650 | 0 | 4 |
_aEpilepsy, Frontal Lobe _xgenetics |
650 | 0 | 4 |
_aHippocampus _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aMuscle Proteins _xbiosynthesis |
650 | 0 | 4 | _aMutation, Missense |
650 | 0 | 4 |
_aNerve Tissue Proteins _xbiosynthesis |
650 | 0 | 4 |
_aNeurotransmitter Agents _xphysiology |
650 | 0 | 4 |
_aNicotine _xpharmacokinetics |
650 | 0 | 4 |
_aParkinson Disease _xprevention & control |
650 | 0 | 4 |
_aReceptors, Nicotinic _xbiosynthesis |
650 | 0 | 4 |
_aSmoking _xmetabolism |
650 | 0 | 4 |
_aTobacco Use Disorder _xgenetics |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
650 | 0 | 4 |
_aVentral Tegmental Area _xdrug effects |
700 | 1 | _aXiao, Cheng | |
700 | 1 | _aSrinivasan, Rahul | |
700 | 1 | _aSon, Cagdas D | |
700 | 1 | _aMiwa, Julie | |
700 | 1 | _aPantoja, Rigo | |
700 | 1 | _aBanghart, Matthew R | |
700 | 1 | _aDougherty, Dennis A | |
700 | 1 | _aGoate, Alison M | |
700 | 1 | _aWang, Jen C | |
773 | 0 |
_tThe AAPS journal _gvol. 11 _gno. 1 _gp. 167-77 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1208/s12248-009-9090-7 _zAvailable from publisher's website |
999 |
_c18719834 _d18719834 |